LAPINE T-LYMPHOCYTE IMMUNE GLOBULIN for Scleroderma: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 7 adverse event reports in the FDA FAERS database where LAPINE T-LYMPHOCYTE IMMUNE GLOBULIN was used for Scleroderma.
Most Reported Side Effects for LAPINE T-LYMPHOCYTE IMMUNE GLOBULIN
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Off label use | 1,231 | 13.3% | 371 | 342 |
| Pyrexia | 865 | 9.3% | 217 | 456 |
| Drug ineffective | 662 | 7.1% | 197 | 240 |
| Product use in unapproved indication | 648 | 7.0% | 174 | 104 |
| Cytomegalovirus infection | 615 | 6.6% | 167 | 196 |
| Cytomegalovirus infection reactivation | 484 | 5.2% | 103 | 166 |
| Post transplant lymphoproliferative disorder | 439 | 4.7% | 214 | 119 |
| Transplant rejection | 437 | 4.7% | 41 | 130 |
| Multiple organ dysfunction syndrome | 379 | 4.1% | 343 | 143 |
| Sepsis | 375 | 4.0% | 242 | 158 |
| Acute kidney injury | 370 | 4.0% | 142 | 228 |
| Pneumonia | 368 | 4.0% | 155 | 152 |
| Cytomegalovirus viraemia | 359 | 3.9% | 64 | 123 |
| Bk virus infection | 356 | 3.8% | 100 | 200 |
| Neutropenia | 338 | 3.6% | 102 | 109 |
Other Indications for LAPINE T-LYMPHOCYTE IMMUNE GLOBULIN
Bone marrow conditioning regimen (1,884)
Immunosuppressant drug therapy (1,597)
Prophylaxis against graft versus host disease (808)
Immunosuppression (789)
Prophylaxis against transplant rejection (780)
Renal transplant (622)
Allogenic stem cell transplantation (539)
Stem cell transplant (442)
Aplastic anaemia (421)
Product used for unknown indication (356)
Other Drugs Used for Scleroderma
AMBRISENTAN (1,547)
RITUXIMAB (252)
METHOTREXATE (145)
MYCOPHENOLATE MOFETIL (144)
LETAIRIS (120)
TOCILIZUMAB (117)
PREDNISONE (83)
SILDENAFIL (78)
BOSENTAN (52)
HYDROXYCHLOROQUINE (49)